文献速递瓣膜外科先天性心脏病外科

儿童与成人患者应用人工新腱索行三尖瓣修复的结局

Outcomes of Tricuspid Valve Repair With Artificial Neochordae in Pediatric and Adult Patients.
PubMed 文献 · Ann Thorac Surg · 2022-02-08

该研究分析了1998年至2020年87例在三尖瓣修复时植入膨体聚四氟乙烯人工新腱索(ePTFE-AN)的连续患者,其中儿童29例、成人58例,均无早期死亡;儿童组3年三尖瓣再干预累积风险为0.0%,成人组为7.3%(95%CI 0.4%-14.2%);两组术后三尖瓣反流分级均显著改善(P < .001),作者认为在先天性三尖瓣反流的成人患者中患者选择对持久结局至关重要。

要点

  • 87例三尖瓣修复时植入ePTFE-AN的患者中,无早期死亡。
  • 儿童组3年三尖瓣再干预累积风险为0.0%,成人组为7.3%(95%CI 0.4%-14.2%)。
  • 两组术后三尖瓣反流分级均显著改善(P < .001)。

核心结论

  • 在三尖瓣位置植入ePTFE-AN可安全有效地实施,无早期死亡。
  • 在先天性三尖瓣反流的成人患者中,患者选择对三尖瓣修复后获得持久结局至关重要。

研究设计与样本

  • 回顾性分析1998年至2020年87例在三尖瓣修复时接受ePTFE-AN植入的连续患者的临床数据。
  • 患者分为儿童组(29例,33.3%)和成人组(58例,66.7%)。

主要发现

  • 三尖瓣反流最常见的病因是先天性(儿童组86.2%[25/29];成人组39.7%[23/59])。
  • 植入ePTFE-AN对数的中位数在儿童组为2对(四分位距2-5对),在成人组为3对(四分位距2-4对)。
  • 无早期死亡;3例成人患者(5.2%)需要早期三尖瓣再手术,4例患者(1例儿童、3例成人)接受了晚期三尖瓣再干预。
  • 需要三尖瓣再干预的6例成人患者中,4例三尖瓣反流病因为先天性。
  • 儿童组3年三尖瓣再干预累积风险为0.0%,成人组为7.3%(95%CI 0.4%-14.2%)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: There are sparse data on outcomes after expanded polytetrafluoroethylene artificial neochordae (ePTFE-AN) for tricuspid valve (TV) repair. We evaluated outcomes after TV repair with ePTFE-AN in both pediatric and adult patients. METHODS: We analyzed clinical data of 87 consecutive patients who underwent ePTFE-AN implantation at the time of TV repair from 1998 to 2020. Patients were categorized into pediatric and adult groups. RESULTS: There were 29 pediatric (33.3%) and 58 adult (66.7%) patients. The most common etiology of tricuspid regurgitation (TR) was congenital (pediatrics: 86.2% [25 of 29]; adults: 39.7% [23 of 59]). The median number of pairs of ePTFE-AN implanted was 2 (interquartile range [IQR], 2-5 pairs) for pediatric and 3 (IQR, 2-4 pairs) for adult patients. There was no early death. Three adult patients (5.2%) required early TV reoperation, and 4 patients (1 pediatric, 3 adults) underwent late TV reintervention. Etiology of TR was congenital in 4 of the 6 adults who required TV reintervention. The 3-year cumulative risk of TV reintervention was 0.0% for pediatric and 7.3% (95% CI, 0.4%-14.2%) for adult patients. There was significant improvement in TR grade after TV repair at dismissal and at the latest echocardiographic follow-up in each group (P < .001). Severe TR developed in 1 pediatric patient and 7 adult patients during follow-up, and 6 (1 pediatric, 5 adults) of them underwent TV reoperation. CONCLUSIONS: ePTFE-AN implantation in the TV position can be performed safely and effectively with no early death. In adult patients with congenital TR, patient selection is critical to achieve a durable outcome after TV repair.

来源:Ann Thorac Surg,查看原文。版权归原作者所有。

引用

  1. Huang Y, Dearani JA, Stephens EH, et al. Outcomes of Tricuspid Valve Repair With Artificial Neochordae in Pediatric and Adult Patients. Ann Thorac Surg. 2022. PMID: 35149047. doi:10.1016/j.athoracsur.2022.01.027

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。